Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design (2023)
- Authors:
- USP affiliated authors: KRONENBERGER, THALES - FCF ; MARANA, SANDRO ROBERTO - IQ ; ALBUQUERQUE, SÉRGIO DE - FCFRP ; EMERY, FLAVIO DA SILVA - FCFRP ; TROSSINI, GUSTAVO HENRIQUE GOULART - FCF ; FERREIRA, GLAUCIO MONTEIRO - FCF
- Unidades: FCF; IQ; FCFRP
- DOI: 10.3390/ph16030428
- Subjects: TRYPANOSOMA CRUZI; ENZIMAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Pharmaceuticals
- ISSN: 1424-8247
- Volume/Número/Paginação/Ano: v. 16 , p. 1-14 art. 428, 2023
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
FERREIRA, Glaucio Monteiro et al. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design. Pharmaceuticals, v. 16 , p. 1-14 art. 428, 2023Tradução . . Disponível em: https://doi.org/10.3390/ph16030428. Acesso em: 28 dez. 2025. -
APA
Ferreira, G. M., Kronenberger, T., Maltarollo, V. G., Poso, A., Gatti, F. de M., Almeida, V. M., et al. (2023). Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design. Pharmaceuticals, 16 , 1-14 art. 428. doi:10.3390/ph16030428 -
NLM
Ferreira GM, Kronenberger T, Maltarollo VG, Poso A, Gatti F de M, Almeida VM, Marana SR, Lopes CD, Tezuka DY, Albuquerque S de, Emery F da S, Trossini GHG. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 428.[citado 2025 dez. 28 ] Available from: https://doi.org/10.3390/ph16030428 -
Vancouver
Ferreira GM, Kronenberger T, Maltarollo VG, Poso A, Gatti F de M, Almeida VM, Marana SR, Lopes CD, Tezuka DY, Albuquerque S de, Emery F da S, Trossini GHG. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 428.[citado 2025 dez. 28 ] Available from: https://doi.org/10.3390/ph16030428 - Fragment screening reveals novel scaffolds against sirtuin-2-related Protein 1 from Trypanosoma brucei
- QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives
- β-amino alcohols and their respective 2-phenyl-N-alkyl aziridines as potential DNA minor groove binders
- Construction and validation of the 3D-structure of T. Cruzi sirtuin-2 by modeling threading
- Synthesis of two 'heteroaromatic rings of the future' for applications in medicinal chemistry
- Synthesis and docking study for compounds analogs of LSD1 inhibitor
- Virtual screening applied in hit identification as LSD1 inhibitors, a epigenetic target for cancer treatment
- Role of a high centrality residue in protein dynamics and thermal stability
- Targeting the Plasmodium falciparum Plasmepsin V by ligand-based virtual screening
- Hologram quantitative structure–activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors
Informações sobre o DOI: 10.3390/ph16030428 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3133258.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
